ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu DANTROLEN i.v.:Norgine AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
M03CA01 - DantroleneATC-DDD Version 2016. Source: WHO
M - Musculo-Skeletal System
 
M03 - Muscle Relaxants

This group comprises peripherally, centrally and directly acting muscle relaxants.
See also G04BD - Drugs for urinary frequency and incontinence.

M03C - Muscle Relaxants, Directly Acting Agents

This group comprises agents acting directly on the muscles such as dantrolene.

M03CA - Dantrolene and Derivatives
 

The DDD of dantrolene is based on the treatment of spasticity after spinal injury.

M03CA01 - Dantrolene
StärkeAdm.RouteNote
 O 
2020 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home